• Lumenis Ltd.
    Cataract/Anterior Segment, Glaucoma, Retina/Vitreous

    Lumenis has filed a registration statement with the Securities and Exchange Commission for a public offering of its ordinary shares.

    Lumenis plans to list them on the Nasdaq Global Market under the ticker symbol "LMNS." The number of shares to be offered and the price range for the offering have not yet been determined.

    Goldman, Sachs & Co., Credit Suisse Securities (USA) LLC and Jefferies LLC will serve as joint bookrunning managers for the proposed offering. Wells Fargo Securities, LLC, will serve as co-manager.

    Lumenis, which is based in Yokneam, Israel, develops and markets medical laser equipment for the ophthalmology, other surgical and aesthetic markets.